WallStreetZen

AnalystsCharles Duncan
Charles Duncan's Stock Forecasts

Analyst Ranking
Top 2%
#46 out of 3474 analysts
Average Return
+73.48%
Win Rate
50%22 out of 44
Risk vs Reward
Poor
Good

Charles Duncan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Novavax IncNVAX
+2,273.26%$9.50$225.46
2020-03-16 -
2021-03-17
Strong Buy
Cassava Sciences IncSAVA
+390.45%$9.32$45.71
2020-10-22 -
2021-10-22
Strong Buy
Aimmune Therapeutics IncAIMT
+175.26%$12.53$34.49
2020-03-22 -
2020-10-12
Strong Buy
Novavax IncNVAX
+169.36%$64.75$174.41
2020-06-18 -
2021-06-18
Strong Buy
Prevail Therapeutics IncPRVL
+103.54%$11.30$23.00
2020-09-10 -
2021-01-21
Strong Buy

Charles Duncan's Stock Coverage

Name / Ticker# of RatingsRatingPrice TargetUpside/DownsideActionDate
Prothena Corp Public Ltd CoPRTA
1Strong Buy$103.00+88.37%Maintains
a month ago
Biohaven Pharmaceutical Holding Co LtdBHVN
4Strong Buy$165.00+20.35%Maintains
a month ago
Cybin IncCYBN
1Strong Buy$9.00+373.68%Initiates Coverage On
2 months ago
ATAI Life Sciences NVATAI
1Strong Buy$45.00+214.25%Initiates Coverage On
4 months ago
Novavax IncNVAX
5Strong Buy$272.00+92.16%Maintains
4 months ago
Clene IncCLNN
1Strong Buy$22.00+293.56%Initiates Coverage On
6 months ago
Ovid Therapeutics IncOVID
1Hold$4.00+15.94%Downgrades
6 months ago
Lumos Pharma IncLUMO
1Strong Buy$32.00+252.42%Initiates Coverage On
a year ago
Cassava Sciences IncSAVA
1Strong Buy$24.00N/AInitiates Coverage On
a year ago
Inovio Pharmaceuticals IncINO
5Hold$12.00N/ADowngrades
a year ago
Prevail Therapeutics IncPRVL
1Strong Buy$26.00N/AInitiates Coverage On
a year ago
Fennec Pharmaceuticals IncFENC
1Strong Buy$18.00N/AInitiates Coverage On
a year ago
Geron CorpGERN
1Strong Buy$4.00N/AMaintains
a year ago
Halozyme Therapeutics IncHALO
2Strong Buy$39.00N/AReiterates
a year ago
Axsome Therapeutics IncAXSM
3Strong Buy$131.00N/AMaintains
2 years ago
Cara Therapeutics IncCARA
1Strong Buy$34.00N/AReiterates
2 years ago
Cytokinetics IncCYTK
1Strong Buy$23.00N/AReiterates
2 years ago
Aimmune Therapeutics IncAIMT
2Strong Buy$32.00N/AMaintains
2 years ago
Acadia Pharmaceuticals IncACAD
4Strong Buy$75.00N/AReiterates
2 years ago
Reata Pharmaceuticals IncRETA
2Strong Buy$320.00N/AReiterates
2 years ago
Intra-Cellular Therapies IncITCI
3Strong Buy$47.00N/AReiterates
2 years ago
Catalyst Pharmaceuticals IncCPRX
1Strong Buy$12.00N/AReiterates
2 years ago
Adamas Pharmaceuticals IncADMS
1Hold$7.00N/AReiterates
2 years ago
Corcept Therapeutics IncCORT
3Hold$14.00N/ADowngrades
3 years ago
Vanda Pharmaceuticals IncVNDA
1Hold$26.00N/AInitiates Coverage On
3 years ago
Acorda Therapeutics IncACOR
1Hold$32.00N/AInitiates Coverage On
3 years ago
vTv Therapeutics IncVTVT
1HoldN/AN/ADowngrades
4 years ago
Sangamo Therapeutics IncSGMO
1Strong BuyN/AN/AUpgrades
4 years ago
Altimmune IncALT
1Strong Buy$6.00N/AInitiates Coverage On
4 years ago
Zynerba Pharmaceuticals IncZYNE
1Strong BuyN/AN/AUpgrades
4 years ago
Pdl Biopharma IncPDLI
1Strong Buy$4.00N/AReinstates
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.